InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-39.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Cline Darren S, Directeur Commercial Principal des États-Unis. Insider active across 2 companies, notably GW Pharmaceuticals PLC. In total, 7 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €167k. History available since 8 December 2021. The latest transaction was disclosed on 26 March 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
35,219 shares0Common StockSEC:0000950170-24-038105:0
139,355 shares0Common StockSEC:0001209191-23-021405:0
66,831 shares0Common StockSEC:0001140361-22-012914:0
10,000 shares@ US$9.38850.058% mcap50.0% of flowCommon StockSEC:0000899243-21-047525:0
Ideal exit: 4 Sept 2022 (T+270)
10,000 shares@ US$9.3885100.0% of flowCommon StockSEC:0000899243-21-047525
Ideal exit: 4 Sept 2022 (T+270)
5,556 sharesOrdinary SharesSEC:0000899243-21-018670
5,556 sharesOrdinary SharesSEC:0000899243-21-018670:0
7 of 7 declarations
About Cline Darren S
Darren S. Cline is the U.S. Chief Commercial Officer and a Board Member at GW Pharmaceuticals PLC and Pyxis Oncology, Inc. In these roles, he is responsible for the strategic and operational leadership of the companies, which specialize in the pharmaceutical sector. Darren plays a key role in growth and innovation, ensuring that the firms meet market needs.
